ILIM
ACOR

Irish Life Investment Managers’s Acorda Therapeutics ACOR Stock Holding History

Irish Life Investment Managers’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q2 		$57.5K Buy
+15
New +$61.8K ﹤0.01% 1267

Other funds holding ACOR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Irish Life Investment Managers's ACOR Position: Q2 2013 in Review

Irish Life Investment Managers opened a new position in Acorda Therapeutics (ACOR) in Q2 2013: 15 shares worth $57.5K. The stake represents ﹤0.01% of the portfolio and ranks #1267 among its holdings.

148 funds tracked by Wall St. Rank hold ACOR as of Q2 2013.

  • Irish Life Investment Managers held 15 shares of Acorda Therapeutics worth $57.5K as of Q2 2013.
  • Acorda Therapeutics was a new Irish Life Investment Managers position in Q2 2013.
  • Acorda Therapeutics made up ﹤0.01% of Irish Life Investment Managers's portfolio in Q2 2013, its #1267 holding.
  • 148 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q2 2013.

Based on Irish Life Investment Managers's 13F filing for Q2 2013, filed 13 Aug 2013.